Maximiliano Kunze-Küllmer

VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech

VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech

Kinetic Investments is a venture capital firm dedicated to early-stage companies that are transforming the digital landscape. Our mission is to drive startup ambitions to definitive successes through strategic investments and dynamic partnerships. Since our inception in 2016, we have invested in 12 transformative startups and been behind over 100+ digital brands. We specialise in pre-seed and seed-stage investments, offering strategic guidance from day one. Our robust operational support and extensive network access is designed to help our portfolio companies scale globally and achieve significant milestones. We are not just investors; we are catalysts for change, committed to shaping the future of digital transformation.

Raising capital from start to finish for Seed to Series B Founders.

A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered

Cells for Cells S.A. is a Chilean-based biotech company dedicated to the research, development and commercialization of cell therapies and tissue-engineered revolutionary solutions. The company counts with a broad portfolio of more than 10 technologies including Cellistem®OA, a clinical trial-supported cell therapy for the treatment of knee osteoarthritis, Inkure®, a bioink for the treatment of focal chondral lesions, Oxium®Exo, a culture media for the production of exosomes, and Veintis™, a bioinspired tissue-engineered vascular graft for vascular bypass applications, among others. Cells for Cells S.A. (a.k.a. C4C) is a spin off from Universidad de los Andes, Chile, and was founded in 2010.